nach oben

memo - Magazine of European Medical Oncology

Erschienen in:

01.09.2020 | editorial

Rectal cancer: latest developments and innovative new treatment concepts

verfasst von: Arno Amann, MD

Erschienen in: memo - Magazine of European Medical Oncology | Ausgabe 3/2020

Einloggen, um Zugang zu erhalten

Auszug

In this special issue of the Magazine of European Medical Oncology (MEMO), a multidisciplinary team of experts summarizes and discusses recent developments and interesting results in rectum carcinoma, from a rising incidence in a young patient cohort to neoadjuvant, palliative and adjuvant treatment protocols. Especially up-front therapy before surgery has been the field within the multimodal treatment of this cancer entity with the most promising and interesting developments over the last year, raising the question of whether surgery is always needed or whether an organ-preserving concept will be the way to go in future. …

Vorheriger Artikel Treatment of advanced melanoma

Nächster Artikel Therapies in flux: highlights of the 2019 San Antonio Breast Cancer Symposium (SABCS)

Zaid AM, Aboelnaga EM, Halim A, Abdelkhalek M, Elbalka SS, Zuhdy M, Fareed AM, Ibrahim EM, Halim H, Metwally IH. Rectal cancer among younger Egyptian patients—clinico-pathological features and oncologic outcomes: A single institution experience. memo 2020. https://doi.org/10.1007/s12254-020-00622-z.CrossRef

Lunger F, Peros G. Chemoradiotherapy alone or chemoradiotherapy followed by surgery in rectal cancer. Which way to go? memo. 2020. https://doi.org/10.1007/s12254-020-00586-0.CrossRef

Arnold CR, Mangesius J, Jäger R, Ganswindt U. Neoadjuvant chemoradiotherapy in rectal cancer. Are there new drug combinations on the horizon? memo. 2020. https://doi.org/10.1007/s12254-020-00594-0.CrossRef

Reichinger A, Rumpold H. Circulating tumour DNA-guided adjuvant chemotherapy in colorectal carcinoma. memo. 2020. https://doi.org/10.1007/s12254-020-00607-y.CrossRef

Witte FH, Hilbe W, Müldür E. Four lines of immunochemotherapy combinations in a young patient with an aggressive metastatic colorectal cancer. memo. 2020. https://doi.org/10.1007/s12254-020-00627-8.CrossRef

Titel: Rectal cancer: latest developments and innovative new treatment concepts
verfasst von: Arno Amann, MD
Publikationsdatum: 01.09.2020
Verlag: Springer Vienna
Erschienen in: memo - Magazine of European Medical Oncology / Ausgabe 3/2020
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076
DOI: https://doi.org/10.1007/s12254-020-00631-y

ASH highlights 2019: “aggressive B-cell lymphoma”

Open Access
short review

Myeloid diseases—Chronic Myeloid Leukemia (CML)—report from ASH 2019 on new developments

short review

Highlights of ASH 2019—multiple myeloma

short review

The therapeutic landscape of advanced melanoma

Open Access
short review

New systemic treatment options in mycosis fungoides and Sézary syndrome

Open Access
short review

Managing an oncology clinic during the COVID-19 pandemic—how we did it in Sarajevo?

editorial

Springer Medizin Österreich

Rectal cancer: latest developments and innovative new treatment concepts

Auszug

Weitere Artikel der Ausgabe 3/2020

ASH highlights 2019: “aggressive B-cell lymphoma”

Myeloid diseases—Chronic Myeloid Leukemia (CML)—report from ASH 2019 on new developments

Highlights of ASH 2019—multiple myeloma

The therapeutic landscape of advanced melanoma

New systemic treatment options in mycosis fungoides and Sézary syndrome

Managing an oncology clinic during the COVID-19 pandemic—how we did it in Sarajevo?

Springer Medizin Österreich

Auszug

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

ASH highlights 2019: “aggressive B-cell lymphoma”

Myeloid diseases—Chronic Myeloid Leukemia (CML)—report from ASH 2019 on new developments

Highlights of ASH 2019—multiple myeloma

The therapeutic landscape of advanced melanoma

New systemic treatment options in mycosis fungoides and Sézary syndrome

Managing an oncology clinic during the COVID-19 pandemic—how we did it in Sarajevo?